Effects of recombinant human growth hormone in catabolic adults with chronic renal failure
Growth hormone (GH) has been used for the treatment of catabolism in a few pilot studies and in twoplacebo-controlled studies of 6 months duration. Treatment with GH in doses of 2-4 IU/m2/day (0.67-1.33 mg/m2/day) resulted in clear anabolic effects and a significant change in body composition. Lean...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2000
|
| In: |
Growth hormone & IGF research
Year: 2000, Volume: 10, Pages: S31-S37 |
| ISSN: | 1532-2238 |
| DOI: | 10.1016/S1096-6374(00)80007-6 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/S1096-6374(00)80007-6 Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S1096637400800076 
|
| Author Notes: | O. Mehls, S. Haas |
| Summary: | Growth hormone (GH) has been used for the treatment of catabolism in a few pilot studies and in twoplacebo-controlled studies of 6 months duration. Treatment with GH in doses of 2-4 IU/m2/day (0.67-1.33 mg/m2/day) resulted in clear anabolic effects and a significant change in body composition. Lean body mass increased by more than 3 kg within 6 months, whereas fat mass was decreased by the same amount, resulting in a constant total body weight. As there were no major side-effects, controlled long-term studies are justified. |
|---|---|
| Item Description: | Available online 3 May 2005 Gesehen am 12.01.2021 |
| Physical Description: | Online Resource |
| ISSN: | 1532-2238 |
| DOI: | 10.1016/S1096-6374(00)80007-6 |